INS and Glucose intolerance: Likewise, data from Fang et al. suggest that chronic treatment with rapamycin in a mixed genetic background results in sustained glucose intolerance, but found that insulin sensitivity as assessed by an insulin tolerance test was dependent upon the length of treatment, with mice treated for 20 weeks actually showing increased insulin sensitivity (albeit glucose intolerance) relative to control mice [18].